Diagnosis and tests 5 min
Stage 4 cancer: what it means and what to expect
What stage 4 means, how it differs from earlier stages, which treatment is possible and why outlook depends heavily on the tumour type.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 23 October 2026
Stage 4 means the cancer has spread beyond the organ where it started: there are metastases in other organs or in lymph nodes far from the tumour. It is not one disease with one outlook: stage 4 breast, lung, bowel cancer or melanoma behave differently.
How it is treated
- Drug treatment is the basis: chemotherapy, targeted therapy, immunotherapy, hormone therapy. The choice depends on the tumour type, its molecular features and your condition.
- Local methods (radiotherapy, surgery, treatment of individual lesions) are added when indicated, for example to control symptoms or for oligometastases.
- Supportive care, such as pain relief, treatment of nausea and anaemia, nutrition support, runs in parallel and is part of treatment.
What the goal of treatment is
In stage 4 treatment is usually aimed at controlling the disease, prolonging life and keeping its quality. For some tumours, effective drugs keep the disease under control for a long time. Specific expectations are discussed with your doctor: they depend on the tumour type and response.
What is most often misunderstood
- “Stage 4 is a death sentence.” No: it describes how far the disease has spread, not a timeline. Many tumours stay under control for years in stage 4.
- “Metastases mean terminal stage.” Terminal stage is a different concept; metastatic disease can be treated for a long time.
- “The stage changes if treatment works.” The original stage at diagnosis stays the same; the condition is described as “response”, “stable disease” or “remission”.
- “All stage 4 is treated the same.” Regimens depend on the organ, subtype and molecular findings.
What the stage is made of
Stage is defined by the TNM system: size and spread of the primary tumour (T), lymph node involvement (N) and the presence of distant metastases (M). Stage 4 usually means distant metastases, that is, the tumour has produced lesions in other organs: liver, lungs, bones, brain or other lymph nodes.
Within stage 4 the spread is huge. One small liver lesion and multiple lesions in several organs are treated differently and have different outlooks.
What treatment in stage 4 depends on
- Tumour type and subtype. In breast cancer, for example, HER2-positive and triple-negative subtypes are treated with different drugs.
- Molecular findings. Mutations and markers (EGFR, ALK, BRAF, MSI and others) open targeted and immune drugs.
- Number and location of lesions. With limited metastases, local treatment is sometimes added.
- General condition and other illnesses.
- Previous treatment and growth rate. That is why two patients with “stage 4” may receive completely different treatment.
Goals of treatment and support
The goal in stage 4 can differ: disease control for years, symptom relief and, in some tumours, for example with limited metastases, even long remission. The doctor should name the goal directly, and you are entitled to ask.
Supportive care is needed alongside: pain relief, nutrition, prevention of clots, psychological support. It is included from the start; it does not replace treatment or mean giving it up. Good practice: discuss goals not once but at every review of the plan.
Oligometastatic disease: when a radical approach is possible
In some patients there are few metastases (usually up to three to five lesions) and they are small. This is called oligometastatic disease. In some tumours (colorectal, kidney, prostate, some lung and breast cancers) local treatment of metastases is added to systemic treatment: surgery, stereotactic radiotherapy, ablation. In selected cases this gives long-term control and rarely cure.
It does not suit everyone, and the decision is made by a tumour board. But if you were told “inoperable, chemotherapy only” and local methods were not discussed, that is a good question for a second opinion.
How often the result is assessed
A control scan (CT, MRI or PET-CT) is usually done every two to four courses, and with targeted and immunotherapy every two to three months. Blood tests, markers and well-being are also followed. If there is an effect, treatment continues; if the disease has grown, the regimen is reviewed. It is good to ask for the monitoring plan in advance: which tests and when.
Do not do scans “for peace of mind” more often than ordered: this adds stress and unnecessary burden, and decisions rarely change because of them.
Questions and mistakes to avoid
- Do not start treatment without pathology and molecular tests, if possible without risk to life.
- Do not decide under pressure of a deadline “within two days” without explanation: urgency can be real, but it is discussed on the merits.
- Do not rely on “folk” methods alone instead of anticancer treatment: this is most often lost time.
- Do not hide symptoms: pain, weight loss, breathlessness affect the choice of treatment.
- Ask about goals and what happens if you decline: how treatment will help and what happens if it is postponed.
- Do not stay alone: a relative at the appointment helps remember what was said.
What to pay attention to
- Has the tumour type been confirmed and have molecular tests that affect drug choice been done?
- Has a tumour board discussed the case and are there alternatives to the proposed regimen?
- Is there access to clinical trials?
If you have been told stage 4 and want to check the plan, I can help you work through it at a consultation.
Sources
- Metastatic Cancer — National Cancer Institute
Frequently asked questions
This article is for information only and does not replace a consultation with your treating doctor. Decisions about tests and treatment are made by the doctor who looks after you.
